149 related articles for article (PubMed ID: 35111244)
1. Association of PD-L1 and ZEB-1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma.
Takamaru N; Fukuda N; Akita K; Kudoh K; Miyamoto Y
Oncol Lett; 2022 Mar; 23(3):75. PubMed ID: 35111244
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma.
Yao X; Sun S; Zhou X; Zhang Q; Guo W; Zhang L
Onco Targets Ther; 2017; 10():781-790. PubMed ID: 28243114
[TBL] [Abstract][Full Text] [Related]
4. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
He J; Chen XF; Xu MG; Zhao J
Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
6. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
7. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Hisakane K; Seike M; Sugano T; Matsuda K; Kunugi S; Nakamichi S; Matsumoto M; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Anticancer Res; 2021 May; 41(5):2501-2509. PubMed ID: 33952478
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition-converted tumor cells can induce T-cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma.
Thar Min AK; Okayama H; Saito M; Ashizawa M; Aoto K; Nakajima T; Saito K; Hayase S; Sakamoto W; Tada T; Hanayama H; Saze Z; Momma T; Ohki S; Sato Y; Motoyama S; Mimura K; Kono K
Cancer Med; 2018 Jul; 7(7):3321-3330. PubMed ID: 29855157
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.
Todoroki K; Abe Y; Matsuo K; Nomura H; Kawahara A; Nakamura Y; Nakamura M; Seki N; Kusukawa J
Oncol Lett; 2024 Feb; 27(2):79. PubMed ID: 38249811
[TBL] [Abstract][Full Text] [Related]
11. Expression of immune checkpoint protein in oral squamous cell carcinoma and its clinicopathological correlation: A tertiary care center cross-sectional study.
Ratnakar S; Kumar M; Maurya MK; Qayoom S; Sagar M; Babu S; Kumar V
J Oral Maxillofac Pathol; 2023; 27(3):597. PubMed ID: 38033955
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.
Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC.
Geum DH; Hwang DS; Lee CH; Cho SD; Jang MA; Ryu MH; Kim UK
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207525
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer.
Murai T; Yamada S; Fuchs BC; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2014 Jun; 109(7):684-9. PubMed ID: 24453058
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Expression in Tumor Cells Is an Independent Unfavorable Prognostic Factor in Oral Squamous Cell Carcinoma.
de Vicente JC; Rodríguez-Santamarta T; Rodrigo JP; Blanco-Lorenzo V; Allonca E; García-Pedrero JM
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):546-554. PubMed ID: 30487133
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma.
Tojyo I; Shintani Y; Nakanishi T; Okamoto K; Hiraishi Y; Fujita S; Enaka M; Sato F; Muragaki Y
Maxillofac Plast Reconstr Surg; 2019 Dec; 41(1):56. PubMed ID: 31857991
[TBL] [Abstract][Full Text] [Related]
19. Expression of PD-L1 and p-RPS6 in epithelial dysplasia and squamous cell carcinoma of the oral cavity.
Hanroongsri J; Amornphimoltham P; Younis RH; Chaisuparat R
Front Oral Health; 2024; 5():1337582. PubMed ID: 38370876
[TBL] [Abstract][Full Text] [Related]
20. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
